TBC1D4 Antibody

Polyclonal Antibody

TBC1D4

Acrg embryonic lethality (mouse) minimal region ortholog antibody, Acrg embryonic lethality minimal region ortholog antibody, Acrg embryonic lethality mouse minimal region ortholog antibody, Akt substrate of 160 kDa antibody, AS 160 antibody, AS160 antibody, BUB2 antibody, CDC16 antibody, KIAA0603 antibody, NIDDM5 antibody, TBC (Tre 2 BUB2 CDC16) domain containing protein antibody, TBC Tre 2 BUB2 CDC16 domain containing protein antibody, TBC1 D4 antibody, TBC1 domain family member 4 antibody, Tbc1d4 antibody, TBCD4_HUMAN antibody, Tre-2 antibody

Synthetic peptide of human TBC1D4

TBC1 domain family member 4 (TBC1D4), also designated AS160, can be insulin- and/or AKT1-induced. Insulin-stimulated phosphorylation is required for GLUT4 translocation. TBC1D4 may play a role as a GTPase activating protein for proteins in the Rab family. It is expressed primarily in skeletal muscle and heart, as well as spleen, lymph node and leukocytes. Defects in the TBC1D4 gene may cause atopic dermatitis (AD), sometimes referred to as eczema, an atopic chronic skin disease. The skin of affected individuals reacts to irritants or allergens and becomes red, flaky and itchy. The skin is also more vulnerable to inflammations, and symptoms can grow or disappear over time.

Antigen Affinity Purified

Signal Transduction

Synthetic peptide of Human TBC1D4